Cargando…
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
BACKGROUND: This study evaluated the safety and immune responses to an autologous dendritic cell vaccine pulsed with class I peptides from tumor-associated antigens (TAA) expressed on gliomas and overexpressed in their cancer stem cell population (ICT-107). METHODS: TAA epitopes included HER2, TRP-2...
Autores principales: | Phuphanich, Surasak, Wheeler, Christopher J., Rudnick, Jeremy D., Mazer, Mia, Wang, HongQian, Nuño, Miriam A., Richardson, Jaime E., Fan, Xuemo, Ji, Jianfei, Chu, Ray M., Bender, James G., Hawkins, Elma S., Patil, Chirag G., Black, Keith L., Yu, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541928/ https://www.ncbi.nlm.nih.gov/pubmed/22847020 http://dx.doi.org/10.1007/s00262-012-1319-0 |
Ejemplares similares
-
Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era
por: Carico, Christine, et al.
Publicado: (2012) -
Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome
por: Nelson, Thomas, et al.
Publicado: (2020) -
Long-term Remission Over Six Years for a Patient with Recurrent Glioblastoma Treated with Cediranib/Lomustine
por: Drazin, Doniel, et al.
Publicado: (2016) -
Post-irradiation lumbosacral radiculopathy associated with multiple cavernous malformations of the cauda equina: Case report and review of the literature
por: Drazin, Doniel, et al.
Publicado: (2017) -
Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
por: Liu, Andy, et al.
Publicado: (2023)